Amrize Ltd SEC Filings

Jan Philipp Jenisch, who serves as Chairman & CEO and a director of Amrize Ltd (AMRZ), reported multiple purchases of the issuer's ordinary shares on 08/11/2025. The reporting person acquired 545,000 ordinary shares directly in several transactions priced roughly between $47.59 and $47.99. An additional 50,000 shares were acquired indirectly by the reporting persons spouse. Following these transactions, the filing shows 1,450,000 shares beneficially owned directly and 450,000 shares beneficially owned indirectly by the spouse. The prices reported reflect conversions from Swiss francs using an exchange rate of USD 1.00 = CHF 0.8084, and the filer offers to provide a full breakdown of the CHF-priced lots upon request.

Jan Philipp Jenisch, Chairman & CEO and director of Amrize Ltd (AMRZ), reported multiple purchases on 08/08/2025 totaling 500,000 ordinary shares — 100,000 acquired directly and 400,000 acquired indirectly by spouse. The trades were executed in Swiss francs at CHF 37.40–CHF 38.44 and converted at the transaction-date rate (USD 1.00 = CHF 0.8086), producing reported USD prices of approximately $46.25–$47.54 per share. Following these transactions the filing shows 905,000 shares beneficially owned directly and 400,000 shares beneficially owned indirectly by spouse. The Form 4 was signed by an attorney-in-fact on 08/12/2025.

James J. Gosa, who is identified as an officer (President, Building Envelope) and a director of Amrize Ltd (AMRZ), was awarded restricted stock units on 08/11/2025 under the Amrize Ltd 2025 Omnibus Incentive Plan. Two awards were reported: 36,952 RSUs that vest on March 21, 2026 and 18,687 RSUs that vest on March 21, 2027. Both grants are recorded with a price of $0.

Following these reported transactions the filing shows the reporting person beneficially owns 55,639 ordinary shares on a direct basis. The entries are presented as non-derivative security acquisitions (restricted stock unit awards) with the vesting schedule and award source explicitly stated in the explanations.

Poletti Samuel Jonas, identified as Chief Strategy & M&A Officer of Amrize Ltd (AMRZ), reported a purchase of ordinary shares on 08/08/2025. The filing shows an acquisition of 1,280 ordinary shares purchased at CHF 37.37 per share, converted at the transaction-date rate (USD 1.00 = CHF 0.8086) to a reported price of $46.22 per share. Following the transaction, the reporting person beneficially owned 3,389 ordinary shares in a direct ownership form.

The Form 4 was submitted by one reporting person and bears a signature dated 08/12/2025 by Hans Weinburger, Attorney-in-Fact. The filing explicitly discloses the currency conversion used for the transaction. No derivative transactions or additional dispositions are reported in this Form 4.

Mario Gross, Chief Supply Chain Officer of Amrize Ltd (AMRZ), reported two open-market purchases of ordinary shares. The filings show purchases of 5,000 shares on 08/08/2025 and 2,600 shares on 08/11/2025, executed in Swiss francs and converted to U.S. dollars at the stated exchange rates. The reported USD-equivalent prices were $46.78 and $47.75 per share. After these transactions Gross beneficially owned 20,232 shares. The Form 4 discloses the transaction codes as purchases and includes conversion details for transparency.

The filing contains only non-derivative purchases and a manual signature by an attorney-in-fact; no options, dispositions, or other compensatory awards are reported.

Amrize Ltd (AMRZ) reporting person Roald Brouwer, identified as Chief Technology Officer and director, purchased ordinary shares across three dates in August 2025. The Form 4 shows purchases of 1,000 shares on 08/08/2025 at $46.25, 1,000 shares on 08/11/2025 (782 at $48.08 and 218 at $48.07), and 1,000 shares on 08/12/2025 at $46.84, bringing his beneficial ownership to 3,000 shares following these transactions. The filing discloses that each purchase was executed in Swiss francs and converted to U.S. dollars using transaction-date exchange rates provided for each trade.

The report is limited to equity purchases and shows no derivative transactions. All amounts and conversion notes are presented on the Form 4; no additional financial results or company-level context are included in this filing.

Denise R. Singleton, listed as Chief Legal Officer & Corp Sec of Amrize Ltd (AMRZ), filed a Form 4 reporting a change in beneficial ownership on 08/08/2025. The filing shows 4,000 ordinary shares associated with a transaction code “P” and a price of $47.64. The Form 4 was signed by Hans Weinburger as attorney-in-fact on 08/11/2025. The filing lists the reporting person as an officer and was filed by one reporting person.

Ian A. Johnston, identified as Chief Financial Officer, executed multiple purchases totaling 10,500 ordinary shares of Amrize Ltd on 08/08/2025 at prices between $47.66 and $47.75 per share. The reported transactions raised his beneficial ownership to 17,344 ordinary shares. The Form 4 lists only non-derivative purchases in separate lots and shows no derivative holdings reported.

UBS Group AG, through its UBS Asset Management division, reports beneficial ownership of 38,197,652 ordinary shares of Amrize Ltd, representing 6.74% of the class. UBS Asset Management reports sole voting power over 35,252,775 shares and shared dispositive power over 38,197,652 shares, indicating voting control for most of its reported position.

The filing identifies UBS Asset Management (Americas) LLC and multiple UBS AM affiliates as included in the disclosure and states accounts are managed on a discretionary basis with rights to dividends or sale proceeds. The filer certifies the holdings were acquired in the ordinary course of business and were not acquired to change or influence control of the issuer.